BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2519 related articles for article (PubMed ID: 26323879)

  • 1. The global burden of IBD: from 2015 to 2025.
    Kaplan GG
    Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):720-7. PubMed ID: 26323879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
    Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of inflammatory bowel disease in Europe.
    Burisch J; Jess T; Martinato M; Lakatos PL;
    J Crohns Colitis; 2013 May; 7(4):322-37. PubMed ID: 23395397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving Epidemiology of IBD.
    Windsor JW; Kaplan GG
    Curr Gastroenterol Rep; 2019 Jul; 21(8):40. PubMed ID: 31338613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
    van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
    Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease: a Canadian burden of illness review.
    Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
    Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.
    Kaplan GG; Ng SC
    Gastroenterology; 2017 Feb; 152(2):313-321.e2. PubMed ID: 27793607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the epidemiology of inflammatory bowel disease in Asia.
    Thia KT; Loftus EV; Sandborn WJ; Yang SK
    Am J Gastroenterol; 2008 Dec; 103(12):3167-82. PubMed ID: 19086963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
    King JA; Underwood FE; Panaccione N; Quan J; Windsor JW; Kotze PG; Ng SC; Ghosh S; Lakatos PL; Jess T; Panaccione R; Seow CH; Ben-Horin S; Burisch J; Colombel JF; Loftus EV; Gearry R; Halfvarson J; Kaplan GG
    Lancet Gastroenterol Hepatol; 2019 Apr; 4(4):287-295. PubMed ID: 30765267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
    Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
    J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert's and patient's perspective.
    Jonaitis L; Marković S; Farkas K; Gheorghe L; Krznarić Ž; Salupere R; Mokricka V; Spassova Z; Gatev D; Grosu I; Lijović A; Mitrović O; Saje M; Schafer E; Uršič V; Roblek T; Drobne D
    BMC Proc; 2021 Dec; 15(Suppl 17):25. PubMed ID: 34879868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of inflammatory bowel disease.
    Loftus EV; Sandborn WJ
    Gastroenterol Clin North Am; 2002 Mar; 31(1):1-20. PubMed ID: 12122726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of inflammatory bowel disease in Asia.
    Sood A; Midha V
    Indian J Gastroenterol; 2007; 26(6):285-9. PubMed ID: 18431013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing epidemiology of inflammatory bowel disease in children and adolescents.
    Long D; Wang C; Huang Y; Mao C; Xu Y; Zhu Y
    Int J Colorectal Dis; 2024 May; 39(1):73. PubMed ID: 38760622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
    Lakatos PL
    World J Gastroenterol; 2006 Oct; 12(38):6102-8. PubMed ID: 17036379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and range of health care consumption under general health insurance and sick leaves among patients with inflammatory bowel disease in chosen countries -- a literature review].
    Petryszyn P; Ziółkowska J; Paradowski L
    Med Pr; 2009; 60(1):59-63. PubMed ID: 19603698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical review of epidemiological studies in inflammatory bowel disease.
    Farrokhyar F; Swarbrick ET; Irvine EJ
    Scand J Gastroenterol; 2001 Jan; 36(1):2-15. PubMed ID: 11218235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the epidemiology of inflammatory bowel diseases].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Feb; 148(5):223-8. PubMed ID: 17344143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The four epidemiological stages in the global evolution of inflammatory bowel disease.
    Kaplan GG; Windsor JW
    Nat Rev Gastroenterol Hepatol; 2021 Jan; 18(1):56-66. PubMed ID: 33033392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 126.